3-Pyridinemethanol - CAS 100-55-0
Catalog: |
BB000258 |
Product Name: |
3-Pyridinemethanol |
CAS: |
100-55-0 |
Synonyms: |
pyridin-3-ylmethanol |
Application: |
3-Pyridinemethanol is a widely used in the synthesis of some inhibitors like Chk1 and histone deacetylase inhibitors. |
IUPAC Name: | pyridin-3-ylmethanol |
Description: | 3-Pyridinemethanol, an aromatic alcohol compound, is a widely used in the synthesis of some inhibitors like Chk1 and histone deacetylase inhibitors. |
Molecular Weight: | 109.13 |
Molecular Formula: | C6H7NO |
Canonical SMILES: | C1=CC(=CN=C1)CO |
InChI: | InChI=1S/C6H7NO/c8-5-6-2-1-3-7-4-6/h1-4,8H,5H2 |
InChI Key: | MVQVNTPHUGQQHK-UHFFFAOYSA-N |
Boiling Point: | 266 °C |
Melting Point: | -7.7 °C |
Purity: | 95 % |
Density: | 1.124 g/cm3 |
Solubility: | 10 mM in DMSO |
Appearance: | Clear light yellow to yellow liquid |
Storage: | 2-8 °C |
MDL: | MFCD00006407 |
LogP: | 0.57390 |
Vapor Pressure: | 0.02 [mmHg] |
GHS Hazard Statement: | H315 (93.1%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-10959933-B1 | Low pH skin care composition and methods of using the same | 20200601 |
US-10980756-B1 | Methods of treatment | 20200316 |
WO-2021123394-A1 | G protein-coupled receptor modulators and a pharmaceutical composition | 20191220 |
WO-2021122415-A1 | Furoindazole derivatives | 20191219 |
WO-2021127677-A1 | Personal care compositions and methods for the same | 20191216 |
PMID | Publication Date | Title | Journal |
22733314 | 20120801 | Novel heneicosadienoic and tricosadienoic acid isomers in ovaries of marine archaeogastropods | Lipids |
20605277 | 20100901 | Copper (II) complexes of the anti-inflammatory drug naproxen and 3-pyridylmethanol as auxiliary ligand. Characterization, superoxide dismutase and catecholase--mimetic activities | European journal of medicinal chemistry |
19902438 | 20100118 | Noncovalent synthesis of hierarchical zinc phosphates from a single Zn(4)O(12)P(4) double-four-ring building block: dimensionality control through the choice of auxiliary ligands | Chemistry (Weinheim an der Bergstrasse, Germany) |
19853978 | 20100101 | The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine | European journal of medicinal chemistry |
20634987 | 20100101 | Synthesis and Structural Characterization of a Metal Cluster and a Coordination Polymer Based on the [Mn(6)(mu(4)-O)(2)] Unit | Bioinorganic chemistry and applications |
Complexity: | 65.5 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 109.052763847 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 109.052763847 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 33.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Pyridines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS